DMTK - Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of DermTech Inc. (DMTK) Investors and Encourages Investors to Contact the Firm Before December 15 2023 | Benzinga

NEW YORK, Oct. 30, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of California on behalf of those who acquired DermTech, Inc. ("DermTech" or the "Company") (NASDAQ:DMTK) securities during the period from May 3, 2022 through November 3, 2022, inclusive (the "Class Period"). Investors have until December 15, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

On August 8, 2022, DermTech announced its second quarter 2022 financial results, reporting that the Company expected a lower average selling price for the DermTech Melanoma Test due to Medicare billing code edits and less favorable collection patterns from commercial payors. On this news, the price of DermTech shares declined by ...

DMTK) Investors and Encourages Investors to Contact the Firm Before December 15, 2023>Full story available on Benzinga.com